Published in Lab Business Week, July 20th, 2008
"The extent is defined as the ratio of free brain concentration to free plasma concentration at steady state. For all central nervous system ( CNS) drug discovery programs, optimization of the extent of brain penetration should focus on designing and selecting compounds having low efflux transport at the blood- brain barrier ( BBB). The time to reach...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2008-07-20)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.